[In the search for effective and safe dose of amikacin in patients with chronic kidney disease].

Unlabelled: The aim of the study was to asses safe and effective amikacin (AMK) doses in patients with different stages of chronic kidney disease.

Material And Methods: The study included 25 patients, among them was 12 (48%) men and 13 (52%) women, aged 73.1 +/- 11.